Skip to Content
주식/증권 📉 부정적

Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.

요약

Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand.